Correlation Between Nuvectis Pharma and Unity Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Unity Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Unity Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Unity Biotechnology, you can compare the effects of market volatilities on Nuvectis Pharma and Unity Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Unity Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Unity Biotechnology.

Diversification Opportunities for Nuvectis Pharma and Unity Biotechnology

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Nuvectis and Unity is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Unity Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Biotechnology and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Unity Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Biotechnology has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Unity Biotechnology go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Unity Biotechnology

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 2.96 times more return on investment than Unity Biotechnology. However, Nuvectis Pharma is 2.96 times more volatile than Unity Biotechnology. It trades about 0.0 of its potential returns per unit of risk. Unity Biotechnology is currently generating about -0.19 per unit of risk. If you would invest  616.00  in Nuvectis Pharma on September 26, 2024 and sell it today you would lose (151.00) from holding Nuvectis Pharma or give up 24.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Nuvectis Pharma  vs.  Unity Biotechnology

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Unity Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Unity Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nuvectis Pharma and Unity Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and Unity Biotechnology

The main advantage of trading using opposite Nuvectis Pharma and Unity Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Unity Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Biotechnology will offset losses from the drop in Unity Biotechnology's long position.
The idea behind Nuvectis Pharma and Unity Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Correlations
Find global opportunities by holding instruments from different markets